Scholarlink

<p>Acute kidney injury (AKI) is a common critical clinical syndrome among hospitalized patients, characterized by high incidence and mortality rates. Currently, the pathogenesis of AKI remains incompletely understood, and effective clinical treatments are lacking. Lactate, a metabolic byproduct of glycolysis, is involved in numerous pathophysiological processes within the kidney and functions as a regulator of lactylation, a recently identified posttranslational modification (PTM). The regulation of lactylation is closely controlled by several key enzymes and metabolic pathways, creating a dynamic and complex modification network. By modulating protein function and gene expression, lactylation significantly impacts the progression of various diseases. Recent evidence suggests that lactylation acts as a pivotal regulatory hub in the pathophysiology of AKI and is intricately linked to core AKI mechanisms, such as inflammation, metabolic reprogramming, and mitochondrial dysfunction. This review presents an investigation of renal lactate metabolism homeostasis and the disruption of this homeostasis, thoroughly discussing the biological underpinnings of lactylation, including the core enzymes involved, and focuses on elucidating the mechanisms of lactylation in AKI. Additionally, the potential of targeting the lactate–lactylation axis as a promising therapeutic strategy for AKI is discussed.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The lactate–lactylation axis in acute kidney injury: mechanisms from metabolic reprogramming to epigenetic regulation and clinical therapeutic prospects

  • 期刊论文

  • 发表日期：

    2026年4月29日

查看全文
  • Jianru Chen,
  • Yijia Zhang,
  • Shaodan Ni,
  • Jieying Qi,
  • Yenan Mo,
  • Xiaoli Nie

摘要

Acute kidney injury (AKI) is a common critical clinical syndrome among hospitalized patients, characterized by high incidence and mortality rates. Currently, the pathogenesis of AKI remains incompletely understood, and effective clinical treatments are lacking. Lactate, a metabolic byproduct of glycolysis, is involved in numerous pathophysiological processes within the kidney and functions as a regulator of lactylation, a recently identified posttranslational modification (PTM). The regulation of lactylation is closely controlled by several key enzymes and metabolic pathways, creating a dynamic and complex modification network. By modulating protein function and gene expression, lactylation significantly impacts the progression of various diseases. Recent evidence suggests that lactylation acts as a pivotal regulatory hub in the pathophysiology of AKI and is intricately linked to core AKI mechanisms, such as inflammation, metabolic reprogramming, and mitochondrial dysfunction. This review presents an investigation of renal lactate metabolism homeostasis and the disruption of this homeostasis, thoroughly discussing the biological underpinnings of lactylation, including the core enzymes involved, and focuses on elucidating the mechanisms of lactylation in AKI. Additionally, the potential of targeting the lactate–lactylation axis as a promising therapeutic strategy for AKI is discussed.